COVID-19 in Cushing disease: experience of a single tertiary centre in Lombardy

J Endocrinol Invest. 2021 Jun;44(6):1335-1336. doi: 10.1007/s40618-020-01419-x. Epub 2020 Sep 11.

Authors

A L Serban^{1

2}, E Ferrante³, G Carosi^{1

2}, R Indirli^{1

4}, M Arosio^{1

4}, G Mantovani^{1

4}

Affiliations

¹ Endocrinology Unit, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, 20122, Milan, Italy.
² Department of Experimental Medicine, Sapienza University of Rome, Rome, Italy.
³ Endocrinology Unit, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, 20122, Milan, Italy. [email protected].
⁴ Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy.

No abstract available

MeSH terms

Adult
Aged
COVID-19 / diagnosis*
COVID-19 / epidemiology*
COVID-19 / therapy
Cohort Studies
Female
Humans
Italy / epidemiology
Male
Middle Aged
Pituitary ACTH Hypersecretion / diagnosis*
Pituitary ACTH Hypersecretion / epidemiology*
Pituitary ACTH Hypersecretion / therapy
Tertiary Care Centers / trends*